Loading...
OTCM
ONPH
Market cap2kUSD
Jun 10, Last price  
0.00USD
1D
0.00%
1Q
9,900.00%
Jan 2017
-99.99%
Name

Oncology Pharma Inc

Chart & Performance

D1W1MN
P/E
—
P/S
0.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
1m
-63.99%
1,031,8581,274,611892,192993,4004,011,7563,672,0003,280,0001,181,000
Net income
-2m
L+2.96%
-2,711,664-2,777,777-2,510,802-4,518,177-1,593,459-1,951,000-1,520,000-1,565,000
CFO
-2m
L+38.50%
-1,884,262-2,524,761-1,706,181-3,422,267-1,401,135-1,450,000-1,444,000-2,000,000

Profile

Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
URL
https://www.oncology-pharma.com/
IPO date
Apr 08, 1994
Employees
Domiciled in
US
Incorporated in
US

Valuation

No data to show